The recommendations have all been written by the named authors and revised by the BIFA committee and BAPEN council.
The briefing also includes information on the citrate content of biosimilars, feedback from patients and clinicians on the patient experience, and reference pricing.
Patient safety and quality improvement are increasingly prioritised across all areas of healthcare.
AGIP encourage the use of these standards within clinical research in order to provide objective evidence of the clinical utility of HMBT.
The December RMOC paper on adalimumab is now available.
Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources
Recently, much attention has focused on social policy and measures to reduce drinking.
UK consensus on non-medical staffing required to deliver safe, quality-assured care for adult patients undergoing gastrointestinal endoscopy
Dunkley I, et al. Frontline Gastroenterology 2018;0:1–11. doi:10.1136/flgastro-2017-100950
The Royal College of Pathologists
Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.